pd 142505-0028 has been researched along with dihydroxyphenylalanine in 1 studies
| Studies (pd 142505-0028) | Trials (pd 142505-0028) | Recent Studies (post-2010) (pd 142505-0028) | Studies (dihydroxyphenylalanine) | Trials (dihydroxyphenylalanine) | Recent Studies (post-2010) (dihydroxyphenylalanine) |
|---|---|---|---|---|---|
| 11 | 1 | 0 | 8,823 | 322 | 833 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augelli-Szafran, CE; Böhme, TM; Hallak, H; Pugsley, T; Schwarz, RD; Serpa, K | 1 |
1 other study(ies) available for pd 142505-0028 and dihydroxyphenylalanine
| Article | Year |
|---|---|
Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.
Topics: Animals; Anthracenes; Binding, Competitive; Biological Availability; Blood-Brain Barrier; Bridged Bicyclo Compounds, Heterocyclic; CHO Cells; Cricetinae; Dihydroxyphenylalanine; Humans; Male; Motor Activity; Muscarinic Agonists; Muscarinic Antagonists; Oxazines; Oximes; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Receptors, Muscarinic; Structure-Activity Relationship | 2002 |